Public

Notice Concerning COVID-19

In an effort to limit the spread of COVID-19 and reduce its impact to our communities, we strongly encourage you to conduct all business with the Board through US mail, email or fax. We will continue to be open for business, but if you are able to conduct business with the Board in other ways, we recommend you not come to the Board office.

Consumer Advisory and Information Concerning COVID-19

The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep people informed on the latest developments. Here is the latest information for consumers on this important topic:

• COVID-19 Frequently Asked Questions (Updated)
• Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
• FDA Working to Protect Consumers Against COVID-19 Vaccine Scams (Update to: FDA Takes Action to Warn and Protect Consumers from Dangerous Alcohol-Based Hand Sanitizers Containing Methanol)
• Free Resources Available to Raise Consumer Awareness of Online COVID-19 Threats
• Help Stop the Spread of Coronavirus and Protect Your Family
• Why You Should Not Use Ivermectin to Treat or Prevent COVID-19
• Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments
• Roundup of Consumer Information About Coronavirus
• Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions

The public should also watch for emails claiming to be from the Centers for Disease Control and Prevention (CDC) or experts saying they have information about the virus. For the most up-to-date information about the Coronavirus, visit the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

Coronavirus Disease 2019 (COVID-19) updates - Actions by FDA in their ongoing response to the COVID-19 pandemic:

• November 17, 2020: COVID-19 Update including information on EUA transparency, an update to SARS-CoV-2 FAQs, and a podcast on personal protective equipment
• November 17, 2020: FDA Authorizes First COVID-19 Test for Self-Testing at Home
• November 17, 2020: FDA’s Ongoing Commitment to Transparency for COVID-19 Emergency Use Authorizations (EUAs)
• November 16, 2020: COVID-19 Update including FDA updates to guidance on investigational COVID-19 convalescent plasma, extending the period of enforcement discretion through the end of February 2021, and a new COVID-19 diagnostic testing web page for health care providers and others
• Bookmark www.fda.gov/coronavirus for the latest.

List of hand sanitizers consumers should not use
Some hand sanitizers have been recalled and there are more than 200 hand sanitizers the FDA recommends you stop using right away. Bookmark www.fda.gov/handsanitizerlist for the latest, and use our step-by-step search guide to find out if your product is on the list.

Fraud Alerts

• Distributor/Customer Product Ordering Scheme (June 2022)
  
  
  

Minnesota PMP

• Request a copy of your PMP report
• Suspected unauthorized access to PMP data

Useful Resources

• Requirements for a Valid Prescription in Minnesota 2019
• AWARXE® Prescription Drug Safety Program
• Locate a Pharmacy that Collects Unwanted Drugs
• Minnesota Department of Health Opioid Dashboard
• Alliance for Safe Online Pharmacies
• NABP Prescription Drug Safety Information
• Safe.Pharmacy

FDA Announcements

• Multilingual COVID-19 Resources
• FDA Warning Concerning Use of Tramadol for Children
• FDA Urges you to Know Your Source for Prescription Drugs
• FDA Sun and Medicine